Ivermectin Approval Campaign
Putting the heart back into philanthropy
Ivermectin Approval Campaign is a UK health and wellbeing project
We want to help people with Covid or Covid Jab Syndrome access timely, safe and effective care
The Ivermectin Approval Campaign is supported by community philanthropy
February 2022 Covid Clinic – Closed
We piloted an online clinic from July to September 2021 and employed three doctors (one full time and two part time) to guide and consult people suffering from covid and its effects. During this time we assisted over 120 people and gained insight into what is needed for a fully-fledged service at a later time. The clinic in its pilot form was not sustainable for a number of reasons, including cost and difficulty staffing the service.
We have learned much from this trial and will be taking the knowledge forward by putting efforts into designing a platform to facilitate access to health practitioners. More news on this soon.
Once again, we thank everyone who donated and made this possible.
The practise of benevolent and charitable acts
The love of humankind in general
We urgently need your support to get effective treatment to those who need it most
This project is in the initial fundraising stage, we do not sell Ivermectin.
If you are still feeling unwell after seeking help from your General Practitioner, you may contact our free Covid Care Clinic via the contact form.
The initial funds will:
- Establish a free Covid Care Clinic to help people with Covid-19 and Covid Jab Syndrome
- Employ Expert Regulatory consultants to prepare:
- Clinical data
- Safety data
- Chemistry, Manufacturing & Controls (CMC) data required to gain Regulatory Approval
- Purchase the first consignment of Ivermectin from a reputable EU source
- Employ regulatory compliant wholesalers to import and ship into the distribution network, according to Rules and Guidance for Pharmaceutical Manufacturers and Distributors
- Contract regulatory compliant UK-based Third-Party Logistics whose role will be to transport supplies direct to where they are needed
We require £150,000 to establish the above, with ongoing support needed to continue our work.
help others by sharing
What is Ivermectin?
Ivermectin is a safe drug that can help prevent and treat Covid-19.
The story of ivermectin goes back 40 years as an incredibly effective anti-parasite drug with a robust safety record. So remarkable in ridding populations of various diseases, that its developers won the Nobel Prize for their work.
Ivermectin is a WHO “Essential Medicine”. These are the “safe and effective” medicines “that every healthcare system should have” – but the NHS does not unfortunately. Ivermectin has been used worldwide in well over 3.8 billion doses.
Over the last year teams of scientists globally have been scrutinising existing licensed drugs to find ones that could help beat the pandemic.
To their delight, the long-established ivermectin has shown very strong antiviral properties in fighting Covid-19. Similar promising results are shown via more studies that are taking place throughout the globe.
The clear evidence from the E-BMC review team showed that people with Covid-19 who were treated with Ivermectin were approximately 70% less likely to die than people who didn’t receive Ivermectin. In practical terms this means that, in a hospital where nine people out of a 100 die from covid, Ivermectin could reduce this number to three per 100. The review also shows that symptoms of the virus were less likely to worsen if a person received Ivermectin.
WHY IS THIS PROJECT IMPORTANT?
The UK does not have a guaranteed supply of Ivermectin which is proven to save lives and reduces transmission of covid-19.
As we looks towards the winter months with government warnings of new variants, it would be ideal if everyone who needs Ivermectin, has access to this safe and effective medicine.
With no conflict of interest, Ivermectin Approval Club wants to ensure that people with covid can access timely, safe and effective treatment and advice.
Who needs Ivermectin?
The UK government has indicated that people who have had covid-19 inoculations are just as likely to be hospitalised with covid-19 than those who have not had them. Thus, everyone in the UK will be needing access to Ivermectin in the upcoming months not just those who opted not to have the injections, to improve recovery from covid-19 and to reduce the chances of being infected.